First Manhattan Co
- SEC CIK
- 0000728083
- Latest filing
- Aug 14, 2026
NBSE holding history
NeuBase Therapeutics, Inc. in every 13F filed by First Manhattan Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NBSE overviewAll 13F holders of NBSEFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −353−100.0% | Sold out | Holders |
| Q1 2024 | 353 | $158 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 353 | $261 | <0.1% | −353−50.0% | Reduced | Holders |
| Q3 2023 | 706 | $614 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 706 | $1.32K | <0.1% | 00.0% | UnchangedConverted for a 1-for-20 split | Holders |
| Q1 2023 | 14,124 | $2.61K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 14,124 | $2.69K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 14,124 | $5.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 14,124 | $14.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 14,124 | $26.0K | <0.1% | +14,124 | New | Holders |